Finance

Lists
Why is 326030 up ၃.၉၆%?
Dive Deeper
326030:KRX
SK Biopharmaceuticals Co Ltd
၇၆,၂၀၀.၀၀ ₩
+၃.၉၆%
(+၂,၉၀၀.၀၀) 1D
အောက် ၁၉, GMT+၉ ၁၅:၃၀:၃၀  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 326030...
Open
၇၃,၁၀၀ ₩
High
၇၆,၄၀၀ ₩
Low
၇၂,၄၀၀ ₩
Mkt. cap
ဋေ ၅.၉၇ သိန်း
Avg. vol.
၁.၀၉ သိန်း
Volume
၉.၀၁ သောင်း
P/E ratio
၁၄.၈၈
52-wk high
၁၄၄,၁၀၀ ₩
52-wk low
၆၇,၈၀၀ ₩
EPS
၅,၁၂၀ ₩
Shares outstanding
၇.၈၃ ကုဋေ
No. of employees
၂၄၆
Open
၇၃,၁၀၀ ₩
High
၇၆,၄၀၀ ₩
Low
၇၂,၄၀၀ ₩
Mkt. cap
ဋေ ၅.၉၇ သိန်း
Avg. vol.
၁.၀၉ သိန်း
Volume
၉.၀၁ သောင်း
P/E ratio
၁၄.၈၈
52-wk high
၁၄၄,၁၀၀ ₩
52-wk low
၆၇,၈၀၀ ₩
EPS
၅,၁၂၀ ₩
Shares outstanding
၇.၈၃ ကုဋေ
No. of employees
၂၄၆
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၀ မိနစ်
S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
Owlting Group (NASDAQ: OWLS) Issues CEO Letter to Shareholders Marking One Year on Nasdaq
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
Leadership Change Could Reset The Case For Erasca (ERAS) Stock
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
The S&P 500's Worst Day Was 39 Years Ago Today. Should You Buy When Stocks Crash?
About SK Biopharmaceuticals Co Ltd
CEO-
Employees၂၄၆
Founded၁၉၉၃
Headquarters-
Sector-
Websiteskbp.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၉၂ သ
ဋေ ၁.၉၄ သ
ဋေ ၂.၂၈ သ
ဋေ ၂.၄၇ သ
Cost of goods sold
၇၅၄.၇၁ ဋေ
ဋေ ၁.၅၀ ထ
ဋေ ၁.၄၃ ထ
ဋေ ၁.၅၀ ထ
Cost of revenue
၇၅၄.၇၁ ဋေ
ဋေ ၁.၅၀ ထ
ဋေ ၁.၄၃ ထ
ဋေ ၁.၅၀ ထ
Research and development expenses
ဋေ ၄.၀၉ ထ
ဋေ ၅.၁၉ ထ
ဋေ ၄.၇၆ ထ
ဋေ ၄.၉၇ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၆.၉၀ ထ
ဋေ ၇.၇၄ ထ
ဋေ ၇.၁၁ ထ
ဋေ ၈.၁၃ ထ
Operating expense
ဋေ ၁.၁၄ သ
ဋေ ၁.၃၃ သ
ဋေ ၁.၂၄ သ
ဋေ ၁.၃၅ သ
Total operating expenses
ဋေ ၁.၂၂ သ
ဋေ ၁.၄၈ သ
ဋေ ၁.၃၈ သ
ဋေ ၁.၅၀ သ
Operating income
ဋေ ၇.၀၁ ထ
ဋေ ၄.၆၃ ထ
ဋေ ၈.၉၈ ထ
ဋေ ၉.၇၁ ထ
Other non operating income
-၈၄၅.၈၉ ဋေ
-၇၅၀.၇၃ ဋေ
-၅၇၈.၃၄ ဋေ
-၅၇၅.၉၀ ဋေ
EBT including unusual items
ဋေ ၆.၂၁ ထ
ဋေ ၃.၃၈ ထ
ဋေ ၁.၀၀ သ
ဋေ ၉.၃၄ ထ
EBT excluding unusual items
ဋေ ၆.၁၃ ထ
ဋေ ၃.၆၇ ထ
ဋေ ၈.၉၉ ထ
ဋေ ၈.၉၈ ထ
Income tax expense
-၉၂၅.၅၂ ဋေ
-ဋေ ၉.၉၀ ထ
-၂၇၅.၆၃ ဋေ
၈၂၉.၅၀ ဋေ
Effective tax rate
-၁၄.၉၀%
-၂၉၃.၁၉%
-၂.၇၆%
၈.၈၈%
Other operating expenses
၁၃၇.၄၁ ဋေ
၁၁၀.၅၈ ဋေ
၂၂၂.၂၄ ဋေ
၁၄၁.၉၅ ဋေ
Net income
ဋေ ၇.၄၁ ထ
ဋေ ၁.၃၇ သ
ဋေ ၁.၀၅ သ
ဋေ ၈.၅၁ ထ
Net profit margin
၃၈.၆၇%
၇၀.၂၈%
၄၆.၁၅%
၃၄.၃၉%
Earnings per share
-
-
-
-
Interest and investment income
၁၈၇.၈၀ ဋေ
၁၇၁.၉၇ ဋေ
၁၆၈.၄၄ ဋေ
၂၃၇.၀၇ ဋေ
Interest expense
-၁၆၉.၈၇ ဋေ
-၁၃၂.၂၆ ဋေ
-၁၃၀.၃၅ ဋေ
-၁၂၅.၇၉ ဋေ
Net interest expenses
၁၇.၉၂ ကုဋေ
၃၉.၇၁ ကုဋေ
၃၈.၀၉ ကုဋေ
၁၁၁.၂၇ ဋေ
Depreciation and amortization charges
၂၂၂.၇၂ ဋေ
၂၁၈.၂၂ ဋေ
၂၁၉.၃၈ ဋေ
၂၁၇.၁၆ ဋေ
EBITDA
ဋေ ၇.၄၁ ထ
ဋေ ၅.၀၂ ထ
ဋေ ၉.၃၇ ထ
ဋေ ၁.၀၁ သ
Gain or loss from assets sale
၁.၀၅ ကုဋေ
၁၇.၆၀ ကုဋေ
-
၁.၀၀ ထောင်
AI content may include mistakes. Learn more
Google အက်ပ်များ